US $16M In a staged capital investment for a leading Colombian supplier of premium cannabis derivatives to the world’s medical, regulated cannabis markets
PRIME LOCATION: Selected through thorough analysis of the Colombian territory, to minimize production costs and mitigate risks.
PREMIUM GENETICS: Fully registered landraces and seeds with a diversity of CBD and THC ratios, capable of serving and customizing to any specification required by customers.
UNPARALLELED HUMAN CAPITAL: Unique International team with global cannabis experience and specialist knowledge in each area required to develop the project
INFRASTRUCTURE EXPERTISE: Company contracted with know-how in building laboratories for the world’s most prestigious pharmaceutical companies.
PRODUCTION CHAIN: Designed for efficient raw primary extract production in Colombia, with EU secondary processing and final origin
PROFITABLE, SUSTAINED GROWTH: Diversified Business Lines, spreading risk, balancing quick wins with long term revenue generation First sales 5 months after the closing of the first financing (clones, cosmetics, vet) Opportunity to learn and adjust, ensuring success of main revenue generator (API) Projected 89% profit margins in year 3
Cash generation after year 2